Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Vivos Therapeutics (VVOS) Shares Issued (2020 - 2025)

Historic Shares Issued for Vivos Therapeutics (VVOS) over the last 5 years, with Q3 2025 value amounting to $1.1 million.

  • Vivos Therapeutics' Shares Issued changed N/A to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 13242.86%. This contributed to the annual value of $7.8 million for FY2024, which is 9490.0% up from last year.
  • Vivos Therapeutics' Shares Issued amounted to $1.1 million in Q3 2025.
  • Vivos Therapeutics' Shares Issued's 5-year high stood at $8.0 million during Q1 2023, with a 5-year trough of -$4.0 million in Q4 2023.
  • Over the past 4 years, Vivos Therapeutics' median Shares Issued value was $3.5 million (recorded in 2024), while the average stood at $2.3 million.
  • Within the past 5 years, the most significant YoY rise in Vivos Therapeutics' Shares Issued was 18750.0% (2024), while the steepest drop was 5073.75% (2024).
  • Over the past 4 years, Vivos Therapeutics' Shares Issued (Quarter) stood at $330000.0 in 2021, then plummeted by 1312.12% to -$4.0 million in 2023, then surged by 187.5% to $3.5 million in 2024, then crashed by 69.26% to $1.1 million in 2025.
  • Its Shares Issued was $1.1 million in Q3 2025, compared to $3.5 million in Q4 2024 and $3.6 million in Q2 2024.